Peter C. Huijgens
- Hematology top 0.2%
- Oncology top 1%
- Pathology and Forensic Medicine top 1%
- Genetics top 0.5%
- Molecular Biology top 10%
- Co-authors
- Leo F. VerdonckB. Mary E. von BlombergBob LöwenbergOtto VisserWim L.J. van PuttenJohanna I.P. de VriesHerman P. van GeijnGert J. Ossenkoppele
- Topics
- Lymphoma Diagnosis and Treatment (42 papers)Acute Myeloid Leukemia Research (32 papers)Multiple Myeloma Research and Treatments (22 papers)
- Cited by
- HematologyGeneticsOncology
- Partner nations
- NetherlandsUnited StatesSwitzerland
In The Last Decade
Peter C. Huijgens
176 papers receiving 6.6k citations
Peers
Comparison fields: 5 of 149
- Hematology 2.5k
- Oncology 2.0k
- Pathology and Forensic Medicine 1.2k
- Genetics 1.1k
- Molecular Biology 1.0k
Countries citing papers authored by Peter C. Huijgens
This map shows the geographic impact of Peter C. Huijgens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Huijgens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Huijgens more than expected).
Fields of papers citing papers by Peter C. Huijgens
This network shows the impact of papers produced by Peter C. Huijgens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Huijgens. The network helps show where Peter C. Huijgens may publish in the future.
Co-authorship network of co-authors of Peter C. Huijgens
This figure shows the co-authorship network connecting the top 25 collaborators of Peter C. Huijgens. A scholar is included among the top collaborators of Peter C. Huijgens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter C. Huijgens. Peter C. Huijgens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 37 | |
| 3 | 3 | |
| 4 | 41 | |
| 5 | 1 | |
| 6 | 46 | |
| 7 | 132 | |
| 8 | 314 | |
| 9 | CONSOLIDATION OF FIRST REMISSION WITH 90Y-IBRITUMOMAB TIUXETAN IN ADVANCED FOLLICULAR NON-HODGKIN'S LYMPHOMA (FL): RESULTS FROM THE PHASE 3 RANDOMIZED FIRST-LINE INDOLENT TRIAL (FIT) | 1 |
| 10 | 345 | |
| 11 | 137 | |
| 12 | 52 | |
| 13 | 6 | |
| 14 | 11 | |
| 15 | 38 | |
| 16 | 4 | |
| 17 | 37 | |
| 18 | 4 | |
| 19 | 12 | |
| 20 | 4 |
About Peter C. Huijgens
Peter C. Huijgens is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 182 papers that have together received 6.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (42 papers), Acute Myeloid Leukemia Research (32 papers) and Multiple Myeloma Research and Treatments (22 papers). The work is most often cited by research in Hematology (2.5k citations), Genetics (1.1k citations) and Oncology (2.0k citations). Peter C. Huijgens has collaborated with scholars based in Netherlands, United States and Switzerland. Frequent co-authors include Leo F. Verdonck, B. Mary E. von Blomberg, Bob Löwenberg, Otto Visser, Wim L.J. van Putten, Johanna I.P. de Vries, Herman P. van Geijn, Gert J. Ossenkoppele, Josée M. Zijlstra and Edo Vellenga. Their work appears in journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.